Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.275 USD | -1.95% | -15.71% | +41.31% |
Mar. 21 | Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC | CI |
Mar. 19 | Fate Therapeutics Prices $100 Million Offering, Private Placement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.31% | 612M | |
-3.17% | 102B | |
+3.38% | 96.09B | |
-1.02% | 22.05B | |
-17.92% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.37% | 14.01B | |
+1.76% | 13.38B | |
+22.84% | 11.01B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Insider Sell: Fate Therapeutics